Allogene announced the futility analysis, which was triggered by the protocol-defined data cutoff of the 24 th patient completing Day 45 minimal residual disease (“MRD”) assessment, showed that 58.3% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results